WILMINGTON, N.C., Jan. 21 /PRNewswire-FirstCall/ -- aaiPharma Inc.
(Nasdaq: AAII) announced today that the Company will release its 2003 fourth
quarter and full-year financial results before the market opens on Thursday,
February 5, 2004.
The Company will host a conference call on Thursday, February 5, 2004 at
8:30 a.m. (ET) to review the 2003 fourth quarter and full-year financial
results. The broadcast will be hosted on the Company's web site located
at http://www.aaipharma.com . A replay of the web cast will be available shortly
after the call.
Please allow extra time prior to the call to visit the site and download
the streaming media software required to listen to the Internet broadcast.
About aaiPharma
aaiPharma Inc. is a leading, science-based pharmaceutical company focused
on pain management, with corporate headquarters in Wilmington, North Carolina.
With more than 24 years of drug development expertise and a proven sales and
marketing track record, the Company is focused on developing, acquiring, and
marketing well-known, branded medicines in its targeted therapeutic areas.
aaiPharma 's development efforts are focused on developing improved medicines
from established molecules through its significant research and development
capabilities. For more information on the Company, including its product
development organization AAI Development Services, please visit aaiPharma's
website at http://www.aaipharma.com .
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
Media, Andrea L. Johnston, Vice President,
Corporate Communications, +1-910-254-7340, or Investors, James B.
Sloan, Jr., Senior Vice President, Corporate Finance,
+1-910-254-7690, both of aaiPharma Inc.
|
